Jessica Fees

All filings by Jessica Fees on record concern Surface Oncology, Inc., in the capacity of finance chief. Over a trading history stretching from 4 January 2019 to 8 September 2023, the count stands at 17 filings.

The open-market record consists of 5 sales worth €150k, with no purchase. Other entries cover 2 share grants and 9 option exercises. Since January 2023: no purchases and 1 sale on the market.

On 8 September 2023 came the latest disclosure, a transaction in Surface Oncology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.